00000nam 2200000za 4500 9.837289 CaOODSP 20221107151113 cr ||||||||||| 160629s2017 onca| #ob f000 0 eng d CaOODSP eng n-cn--- H82-28/2017E-PDF Canada. Health Canada. Protecting Canadians from excessive drug prices [electronic resource] : consulting on proposed amendements to the Patented Medicines Regulations. Consulting on proposed amendements to the Patented Medicines Regulations [Ottawa] : Health Canada, 2017. 16 p. : col. ill. Cover title. "This consultation period is 6 weeks, running from May 16, 2017 to June 28, 2017"--p. 5. Issued also in French under title: Protéger les Canadiens des prix excessifs des médicaments : consultation sur les modificaations proposées au Règlement sur les médicaments brevetés. Includes bibliographical references. "In January 2016, federal, provincial and territorial Ministers agreed to work together to improve the affordability, accessibility and appropriate use of prescription drugs to better meet health care system needs. ... This important work includes reducing the cost of patented drugs through the modernization of the pricing framework under the Patented Medicine Prices Review Board (PMRPB). Under the authority of the Patent Act and through the Patented Medicines Regulations (“Regulations”), the Government of Canada regulates the prices of patented medicines in Canada to ensure that prices are not excessive. Despite significant changes in the pharmaceutical market, the regulations have not been substantively changed in over two decades. Health Canada is consulting stakeholders and interested members of the public on proposed amendments to the Regulations, to equip the PMPRB with more relevant and effective regulatory tools to better protect Canadians from excessive prices for patented drugs. ... Feedback received on or before June 28th, 2017, will be considered in developing a regulatory proposal under the Patent Act to protect Canadians from excessive drug prices. A summary of comments will be published in the RIAS statement at Canada Gazette, Part I"--p. 3 and p. 16. gccst Drugs gccst Price regulation gccst Reform gccst Consultations Canada. Patented Medicine Prices Review Board. Protéger les Canadiens des prix excessifs des médicaments (CaOODSP)9.837292 PDF 1.18 MB https://publications.gc.ca/collections/collection_2017/sc-hc/H82-28-2017-eng.pdf